Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 224

1.

Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures.

Jeremias A, Baim DS, Ho KK, Chauhan M, Carrozza JP Jr, Cohen DJ, Popma JJ, Kuntz RE, Cutlip DE.

J Am Coll Cardiol. 2004 Sep 15;44(6):1210-4.

2.

Increased creatine kinase MB level predicts postoperative mortality after cardiac surgery independent of new Q waves.

Ramsay J, Shernan S, Fitch J, Finnegan P, Todaro T, Filloon T, Nussmeier NA.

J Thorac Cardiovasc Surg. 2005 Feb;129(2):300-6.

4.
5.

Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.

Delhaye C, Sudre A, Lemesle G, Maréchaux S, Broucqsault D, Hennache B, Bauters C, Lablanche JM.

Cardiovasc Revasc Med. 2009 Jul-Sep;10(3):144-50. doi: 10.1016/j.carrev.2009.01.005.

PMID:
19595394
6.

Prognostic value of recurrent episodes of creatine kinase-MB elevation following repeated catheter-based coronary interventions.

Kornowski R, Fuchs S, Hong MK, Mehran R, Satler LF, Pichard AD, Kent KM, Stone GW, Leon MB.

Catheter Cardiovasc Interv. 2000 Oct;51(2):131-7.

PMID:
11025563
7.

Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality.

Hong MK, Mehran R, Dangas G, Mintz GS, Lansky AJ, Pichard AD, Kent KM, Satler LF, Stone GW, Leon MB.

Circulation. 1999 Dec 14;100(24):2400-5.

8.

Periprocedural myocardial infarction in a randomized trial of everolimus-eluting and Paclitaxel-eluting coronary stents: frequency and impact on mortality according to historic versus universal definitions.

Pervaiz MH, Sood P, Sudhir K, Hermiller JB, Hou L, Hattori K, Su X, Cao S, Wang J, Applegate RJ, Kereiakes DJ, Yaqub M, Stone GW, Cutlip DE.

Circ Cardiovasc Interv. 2012 Apr;5(2):150-6. doi: 10.1161/CIRCINTERVENTIONS.111.965566. Epub 2012 Mar 20.

9.

Impact of sodium-hydrogen exchange inhibition by cariporide on death or myocardial infarction in high-risk CABG surgery patients: results of the CABG surgery cohort of the GUARDIAN study.

Boyce SW, Bartels C, Bolli R, Chaitman B, Chen JC, Chi E, Jessel A, Kereiakes D, Knight J, Thulin L, Theroux P; GUARD During Ischemia Against Necrosis (GUARDIAN) Study Investigators.

J Thorac Cardiovasc Surg. 2003 Aug;126(2):420-7.

10.

Predictors of mortality at 30 days in high-risk patients treated with direct or rescue stenting for acute myocardial infarction: a single center experience.

La Vecchia L, Martini M, Sartori M, Vincenzi P, Cischele L, Righetti T, Ometto R, Fontanelli A.

J Invasive Cardiol. 2001 Oct;13(10):689-93.

PMID:
11581511
11.

Creatine kinase-MB fraction elevation after percutaneous coronary intervention in patients with chronic renal failure.

Gruberg L, Mehran R, Waksman R, Dangas G, Fuchs S, Wu H, Kent KM, Pichard AD, Satler LF, Stone GW, Leon MB.

Am J Cardiol. 2001 Jun 15;87(12):1356-60.

PMID:
11397353
12.

Troponin T elevation after successful directional atherectomy.

Giannitsis E, von Lippa I, Müller Bardorff M, Wiegand U, Kübler W, Katus HA.

Z Kardiol. 2001 Jun;90(6):401-7.

PMID:
11486574
13.
14.

Electrocardiographic and hemodynamic changes and their association with myocardial infarction during coronary artery bypass surgery. A multicenter study. Multicenter Study of Perioperative Ischemia (McSPI) Research Group.

Jain U, Laflamme CJ, Aggarwal A, Ramsay JG, Comunale ME, Ghoshal S, Ngo L, Ziola K, Hollenberg M, Mangano DT.

Anesthesiology. 1997 Mar;86(3):576-91.

PMID:
9066323
15.
16.

Clinical outcomes after percutaneous coronary intervention with drug-eluting stents in dialysis patients.

Hassani SE, Chu WW, Wolfram RM, Kuchulakanti PK, Xue Z, Gevorkian N, Suddath WO, Satler LF, Kent KM, Pichard AD, Weissman NJ, Waksman R.

J Invasive Cardiol. 2006 Jun;18(6):273-7.

PMID:
16751681
17.

Myonecrosis following stent placement: association between impaired TIMI myocardial perfusion grade and MRI visualization of microinfarction.

Choi JW, Gibson CM, Murphy SA, Davidson CJ, Kim RJ, Ricciardi MJ.

Catheter Cardiovasc Interv. 2004 Apr;61(4):472-6.

PMID:
15065140
18.

Myonecrosis after revascularization procedures.

Califf RM, Abdelmeguid AE, Kuntz RE, Popma JJ, Davidson CJ, Cohen EA, Kleiman NS, Mahaffey KW, Topol EJ, Pepine CJ, Lipicky RJ, Granger CB, Harrington RA, Tardiff BE, Crenshaw BS, Bauman RP, Zuckerman BD, Chaitman BR, Bittl JA, Ohman EM.

J Am Coll Cardiol. 1998 Feb;31(2):241-51. Review.

19.

Predictors of death or myocardial infarction during follow-up after coronary stenting with the sirolimus-eluting stent. Results from the prospective multicenter German Cypher Stent Registry.

Zahn R, Hamm CW, Schneider S, Zeymer U, Richardt G, Kelm M, Levenson B, Bonzel T, Tebbe U, Sabin G, Nienaber CA, Senges J; German Cypher Stent Registry.

Am Heart J. 2006 Dec;152(6):1146-52.

PMID:
17161068

Supplemental Content

Support Center